7 funding opportunities found in this category. Change the order of results:
Lowest Award to Highest
Highest Award to Lowest
American Association for Cancer Research-Ocular Melanoma Foundation Fellowship
Application deadline: Dec. 17, 2013, at noon, Eastern Time
Decision date: March 2014
Annual Grants Reception and Dinner at AACR Annual Meeting 2014: April 8, 2014 - Grant recipient must attend the Grants Reception and Dinner and formally accept the grant. Grant funds may be used to support the grantee’s attendance at this Annual Meeting; complimentary registration will be provided.
Start of grant term: July 1, 2014
The AACR-Ocular Melanoma Foundation Fellowship represents a joint effort to encourage and support a postdoctoral or clinical research fellow to conduct ocular/uveal melanoma research and to establish a successful career path in ophthalmology, ocular oncology, uveal melanoma cancer biology, or similar field. The research proposed for funding may be basic, translational, or clinical in nature and must have direct, primary applicability and relevance to ocular/uveal melanoma.
The fellowship provides a one-year grant of $50,000 to support the salary and benefits of the fellow while working on a mentored ocular/uveal melanoma research project. A partial amount of the funds may be designated for nonpersonnel expenses, such as research/laboratory supplies, equipment, publication charges for manuscripts that pertain directly to the funded project, and other research expenses.
It is anticipated that one fellowship will be funded.
Applicant Eligibility Criteria
Applicants must have a medical and/or doctoral degree (including Ph.D., M.D., D.O., D.C., N.D., D.D.S., D.V.M., Sc.D., D.N.S., Pharm.D., or equivalent doctoral degree) in a related field and not currently be a candidate for a further doctoral or professional degree.
At the start of the grant term on July 1, 2014, applicants must:
Be in the first five years of a postdoctoral or clinical research fellowship (i.e., must have started fellowship no earlier than July 2, 2009, and no later than July 1, 2014); and
Work under the auspices of a mentor at an academic, medical, or research institution anywhere in the world. (There are no citizenship or geographic requirements; however, an applicant applying from an institution located within a country where he or she is not a citizen or permanent resident, by submitting an application for this grant, assures that his/her visa status will provide sufficient time to complete the project and grant term at the institution from which they applied.)
For applicants possessing an M.D., clinical training time with no research involvement (e.g., residency training) is not included against the eligibility limit. Parental leave or other well justified leave from mentored research training for pressing personal or family situations of generally less than 12 months duration is also not included against the eligibility limit for all applicants.
Employees or subcontractors of a U.S. government entity or for-profit private industry are not eligible.
AACR membership is required. Nonmembers interested in this grant opportunity must submit a satisfactory application for AACR associate membership by Thursday, Dec. 19, 2013. The application will be applied to 2013 membership dues.
All applicants with questions about eligibility should contact the AACR before submitting an application.
Research Project Criteria
Research must have direct applicability and relevance to ocular/uveal melanoma and may be in any discipline of basic, clinical, or translational research. The research must have direct, primary applicability and relevance to ocular/uveal melanoma or, if applicable to cutaneous melanoma as well, be focused primarily on uveal melanoma and its specific cancer biology.
Generously Supported By
Ocular Melanoma Foundation
Glaucoma Foundation Research Grant Program
The Glaucoma Foundation offers grants to researchers striving to improve the lives of glaucoma patients through novel innovations and scientific advances. The area of current focus for TGF's Grant Research program is exfoliation syndrome and exfoliation glaucoma. The next deadline for grant applications is March 1, 2014. (This will be TGF's only deadline in 2014). Initial grant funding for a one-year period is for up to $40,000; a grantee is permitted to apply for a grant renewal of up to $50,000. A renewal grant is a one year grant based upon research findings from the initial research.
A. Please read through the application carefully and include all the required information. There are five parts to this application:
1. A Summary and Information Sheet
2. A Supplemental Information section
3. A Budget Form and an Other Funding portion
4. A Project Description
5. A Biographical sketch.
Please make sure each section is complete.
B. Submit one original and five copies of the completed application and related appendices. Please also include a self-addressed, stamped postcard for confirmation receipt of the application.
C. Submit a PDF of your application to email@example.com
D. For general application questions and mail applications to:
Director of Outreach Programs
The Glaucoma Foundation
80 Maiden Lane, Suite 700
New York, NY 10038
For technical questions, please contact:
Robert Ritch, MD
Medical Director, Vice President, Secretary and Founder, TGF
Professor and Chief, Glaucoma Service
The New York Eye & Ear Infirmary
310 East 14th Street
New York, NY 10003
Proposals will be evaluated only in March 2014. Applications submitted for the March deadline will be awarded in June.
Terms and Restrictions
A. Grants are awarded for a one-year period and are renewable.
B. Applicants must clearly demonstrate the Principal Investigator’s understanding of glaucoma or his/her collaboration with an investigator who has experience in glaucoma research. If collaboration is warranted, a letter of support from the researcher must be included in the application.
C. Applicants must have a full time faculty position or equivalent.
D. Initial grant funding for a one-year period is limited to a maximum of $40,000. The Principal Investigator may apply for a renewal for up to $50,000. Renewal grants are for an additional year of research and must be based upon findings from the first year’s work.
E. The Glaucoma Foundation does not provide funds for investigator salaries, travel, overhead, or other indirect costs.
F. Excluding renewal grants, Principal Investigators are required to wait a minimum of two years from the funded cycle before submitting a new research application for consideration.
G. Renewal grant applications are accepted after 18 months have elapsed from the beginning of an original grant award.
Merck Innovative Ophthalmology Research Awards
The ARVO Foundation is pleased to offer this series of biennial awards. The Merck Innovative Ophthalmology Research Awards (IORA) encourages young researchers to undertake investigative work in critical areas of ophthalmology that may one day lead to meaningful improvements in patients' lives. It is open to researchers aged 45 years or younger who hold an MD, a PhD or an equivalent doctoral level degree. A first place prize of $15,000 and two second place prizes of $10,000 will be awarded in each of two categories for a total of $70,000 in awards.
Topics for the 2015 awards are:
• Ocular Surface
2015 Merck Ophthalmology Research Award timeline
Nominations open Dec. 2, 2013
Nominations close Nov. 3, 2014
Awardees notified by January 2015
For additional information, please contact Andrew Dobos at 240-221-2951.
Dr. Roger Vogel Award for Pharmaceutical Research
The nomination form must be submitted with all its constituents before the Dec. 27, 2013 deadline
The award will be given to honor an ARVO member who has made significant contributions to the discovery or development of pharmaceutical products to treat eye diseases. The award will be based on the overall contributions of the individual to pharmaceutical research.
The recipient can be any member of ARVO, including practicing physicians and researchers working in academia or industry.
There are no geographic restrictions (i.e., international or domestic).There are no age restrictions.
The award will consist of a cash award of $10,000 and a suitably inscribed plaque. The recipient will be clearly identified in the ARVO Annual Meeting program as the Dr. Roger Vogel Award recipient.
The following is required to complete the nomination:
• The nomination form
• One nomination letter
• Secondary letter
Review ProcessThe ARVO Foundation Awards Committee will review all nominations and select a winner.
Call for Nominations: Association for Research in Vision and Ophthalmology Achievement Awards
The deadline for nominations is March 3, 2014.
The ARVO Achievement Awards honor individuals for their exceptional contributions to ophthalmology and visual science. All awards are presented during the ARVO Annual Meeting each May. Nominations for the prestigious awards are open to all members of the vision research community. There are no membership or geographical restrictions for nominees or nominators.
2015 ARVO Achievement Award nominations are open.
The Proctor Medal was established in 1949 as a memorial to Dr. Francis I. Proctor, an ophthalmologist who conducted extensive research on the etiology and treatment of trachoma.
This award honors outstanding research in the basic or clinical sciences as applied to ophthalmology. This was the first ophthalmology-related award to honor non-clinicians in the field. The recipient presents the Proctor Award Lecture at the ARVO Annual Meeting and receives the Proctor Medal, complimentary registration, hotel and travel, and per diem.
The Friedenwald Award was established in 1957 as a memorial to Dr. Jonas S. Friedenwald, a distinguished researcher whose contributions encompassed the entire field of ophthalmic investigations. His pioneer studies on the pathogenesis of glaucoma, corneal wound healing and diseases of the retina laid the groundwork for future generations of investigators.
Like the Proctor Medal, this award honors outstanding research in the basic or clinical sciences as applied to ophthalmology. The Award recipient presents the Friedenwald Award Lecture at the ARVO Annual Meeting, and receives a plaque, complimentary registration, hotel and travel, and per diem.
Mildred Weisenfeld Award for Excellence in Ophthalmology
This award was established as a tribute to Mildred Weisenfeld's outstanding contributions to the field, which include the founding of Fight for Sight in 1946. As a young woman with retinitis pigmentosa, she found support was directed to charitable assistance for those with vision disorders. She believed that by encouraging research and researchers, the result would have a greater impact. This award is presented to an individual in recognition of distinguished scholarly contributions to the clinical practice of ophthalmology. The recipient presents the Weisenfeld Award Lecture at the ARVO Annual Meeting and receives a plaque, complimentary registration, hotel and travel, and per diem.
The Cogan Award was established in 1988 to commemorate Dr. David G. Cogan, for his outstanding leadership and commitment to advancing the understanding of the causes, mechanisms, and treatment of human eye disease.
This award is intended to recognize a young researcher who is 45 years of age or younger at the time of nomination, and who has made important and worthwhile contributions to research in ophthalmology or visual science that are directly related to disorders of the human eye or visual system, and who show substantial promise for future contributions. The recipient presents the Cogan Award Lecture at the ARVO Annual Meeting and receives a plaque, complimentary registration, hotel and travel, and per diem. Cogan Award recipients are eligible to receive one of the other ARVO awards at a later date.
The Kupfer Award was first presented in 1993 to Dr. Carl Kupfer, who served as Director of the National Eye Institute, U.S. National Institutes of Health, for 30 years.
This award honors those who have demonstrated distinguished public service with national or global impact, on behalf of eye and vision research. Recipients receive a plaque which is presented at the ARVO Annual Meeting, complimentary registration, hotel and travel, and per diem.
Joanne G. Angle Award
The Joanne G. Angle Award is the highest service honor to a volunteer professional bestowed by ARVO. This award was first presented in 2012 posthumously to Joanne G. Angle, ARVO Executive Director for 22 years.
This award recognizes outstanding leaders who have made significant, continuous contributions to ARVO in support of its mission. The recipient will show obvious personal involvement in and commitment to ARVO as well as contributions to the vision research community. The recipient is presented a plaque during the ARVO Annual Meeting.
Special Recognition Award
The Special Recognition Award is presented periodically to honor outstanding service to ARVO or the vision research community. Recipients receive a plaque that is presented at the ARVO Annual Meeting, complimentary registration, hotel and travel, and per diem.
Distinguished Service Award
The Distinguished Service Award is presented to elected ARVO officers and editors-in-chief upon completion of their terms, in appreciation for dedicated service to ARVO. The recipients are presented a plaque during the ARVO Annual Meeting.
Velux Stiftung Research Grant Program
The Velux Stiftung was established in 1980 and promotes research projects investigating the effect and better utilisation of daylight. The Velux Stiftung is interested in the effect of daylight on the well-being of humans and on the recovery process from both physical and psychological illness, but also its impact on nature, and in technologies for the utilisation of daylight in buildings for energy efficiency and illumination.
The Velux Stiftung is active world-wide, and supports innovative projects which generate lasting progress for the benefit of mankind.
The Velux Stiftung is member of SwissFoundations.
The foundation – which is a non-profit organisation – supports research projects:
- related to the use, the impact or the benefit of daylight,
- for the better understanding and the furtherance of normal aging
- in ophthalmology
Applications submitted to the Velux Stiftung have to be within the foundation's aims and purposes, and need to fulfill the requested conditions.
For any questions, please do not hesitate to contact us.
"Zum Rothen Adler"
Research to Prevent Blindness Grants Program
Applications for RPB grants must be submitted by the chairman of a department of ophthalmology and are then evaluated via a three-tiered review process. RPB Ad Hoc Committees, which are comprised of selected national vision research leaders, conduct initial grant reviews and forward their recommendations to the standing RPB Scientific Advisory Panel for further evaluation. The Advisory Panel includes some of the nation's most distinguished scientists representing a broad range of scientific disciplines and interests. Their recommendations are presented to the RPB Board of Trustees for final approval.
Please note: Grant applications are not available on RPB's website. For complete grant guidelines and applications, or if you have any questions regarding RPB's Grants Program, contact RPB's Grant Administrator at 212.752.4333 or firstname.lastname@example.org.
RPB accepts grant applications twice a year, January 1st and July 1st.